Skip to main content
. Author manuscript; available in PMC: 2008 Feb 25.
Published in final edited form as: J Neuropathol Exp Neurol. 2007 Jan;66(1):75–85. doi: 10.1097/nen.0b013e31802d6da9

TABLE 2.

Antibody Information

Antigen Clone or Catalog Dilution TSA Species Application Manufacturer
Nrf2 H300 1:200 Yes Rb IHC, IF Santa Cruz Biotechnology, Santa Cruz, CA
Nrf2 C20 1:2,000 Yes Rb IHC, IF Santa Cruz Biotechnology
Nrf2 KAP-TF125 1:200 Yes Rb IHC Stressgen, Victoria, BC, Canada
Nrf2 H300 1:1000 No Rb IB Santa Cruz Biotechnology
GFAP Z0334 1:80 No Rb IF DAKO, Carpinteria, CA
MAP2 SMI-52 1:500 No Ms IF Covance, Berkeley, CA
HNE HNE11-S 1:50 No Rb IF Alpha Diagnostics International, San Antonio, TX
GAPDH MAB374 1:100 No Ms IB Chemicon International, Temecula, CA
APP, amyloid fragment 4G8 1:20,000 No Ms IF Gift from Drs. Lee and Trojanowski, University of Pennsylvania
NFT AT8 1:300 No Ms IF Pierce, Rockford, IL,

Summary of antibodies used in this study are shown. If antibody staining was amplified with tyramide amplification system (TSA) for immunofluorescent or immunostaining, it is indicated (yes). The species of animal in which the primary antibody was raised is indicated (species; mouse—Ms, rabbit—Rb). Applications using antibodies include immunohistochemistry (IHC), immunofluorescence (IF), and immunoblotting (IB).

Nrf2, nuclear factor E2-related factor 2; GFAP, glial fibrillary acid protein; MAP2, microtubule associate protein 2; HNE, hydroxylnonenal; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; APP, amyloid precursor protein; NFT, neurofibrillary tangle.